0.5423
price down icon2.60%   -0.0145
after-market After Hours: .55 0.0077 +1.42%
loading
Century Therapeutics Inc stock is traded at $0.5423, with a volume of 446.57K. It is down -2.60% in the last 24 hours and up +10.25% over the past month. Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
See More
Previous Close:
$0.5568
Open:
$0.5579
24h Volume:
446.57K
Relative Volume:
0.61
Market Cap:
$46.85M
Revenue:
$2.24M
Net Income/Loss:
$-136.67M
P/E Ratio:
-0.2368
EPS:
-2.29
Net Cash Flow:
$-102.08M
1W Performance:
-4.64%
1M Performance:
+10.25%
6M Performance:
-0.26%
1Y Performance:
-65.46%
1-Day Range:
Value
$0.54
$0.563
1-Week Range:
Value
$0.5236
$0.59
52-Week Range:
Value
$0.3418
$1.83

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
Name
Century Therapeutics Inc
Name
Phone
215-981-4000
Name
Address
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
Employee
165
Name
Twitter
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
IPSC's Discussions on Twitter

Compare IPSC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IPSC
Century Therapeutics Inc
0.5423 48.10M 2.24M -136.67M -102.08M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-08-24 Initiated Rodman & Renshaw Buy
Aug-28-23 Downgrade JP Morgan Overweight → Neutral
Dec-27-22 Initiated Chardan Capital Markets Buy
Oct-31-22 Initiated Guggenheim Buy
Oct-10-22 Initiated Canaccord Genuity Buy
May-23-22 Initiated H.C. Wainwright Buy
May-12-22 Initiated William Blair Mkt Perform
Jul-13-21 Initiated BofA Securities Buy
Jul-13-21 Initiated JP Morgan Overweight
Jul-13-21 Initiated Piper Sandler Overweight
View All

Century Therapeutics Inc Stock (IPSC) Latest News

pulisher
Oct 17, 2025

Is Century Therapeutics Inc. stock supported by strong fundamentalsJuly 2025 Outlook & Reliable Trade Execution Plans - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

Is Century Therapeutics Inc. building a consolidation baseJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

How to use a screener to detect Century Therapeutics Inc. breakoutsEarnings Summary Report & Daily Momentum Trading Reports - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Does Century Therapeutics Inc. show high probability of reboundJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com

Oct 17, 2025
pulisher
Oct 16, 2025

How to manage a losing position in Century Therapeutics Inc.Share Buyback & Consistent Income Trade Recommendations - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Century Therapeutics Inc. stock momentum explainedRisk Management & Consistent Income Trade Recommendations - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Is Century Therapeutics Inc. stock reversal real or fakeProduct Launch & Verified Momentum Stock Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Can Century Therapeutics Inc. recover in the next quarterMarket Activity Summary & Consistent Income Trade Recommendations - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference - GlobeNewswire

Oct 14, 2025
pulisher
Oct 14, 2025

Century Therapeutics Inc. stock volume spike explainedTrade Analysis Report & Fast Momentum Entry Tips - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Is Century Therapeutics Inc. stock positioned well for digital economyPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How Century Therapeutics Inc. stock trades before earningsWeekly Loss Report & Community Driven Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Will Century Therapeutics Inc. rebound enough to break evenJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is now a turning point for Century Therapeutics Inc.July 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Applying chart zones and confluence areas to Century Therapeutics Inc.2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

We Think Century Therapeutics (NASDAQ:IPSC) Needs To Drive Business Growth Carefully - Yahoo Finance

Oct 12, 2025
pulisher
Oct 12, 2025

Century Therapeutics (NASDAQ:IPSC) Upgraded by Wall Street Zen to Hold Rating - Defense World

Oct 12, 2025
pulisher
Oct 10, 2025

Century Therapeutics Inc. stock outlook for YEARMarket Volume Report & Fast Exit/Entry Strategy Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Does Century Therapeutics Inc. fit your quant trading modelJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What the charts say about Century Therapeutics Inc. today2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Critical Analysis: Century Therapeutics (NASDAQ:IPSC) and TransCode Therapeutics (NASDAQ:RNAZ) - Defense World

Oct 09, 2025
pulisher
Oct 08, 2025

Layoff Tracker: Novo’s Cuts Leave Dozens of Manufacturing Workers Jobless - BioSpace

Oct 08, 2025
pulisher
Oct 08, 2025

There Is A Reason Century Therapeutics, Inc.'s (NASDAQ:IPSC) Price Is Undemanding - simplywall.st

Oct 08, 2025
pulisher
Oct 06, 2025

How to escape a deep drawdown in Century Therapeutics Inc.July 2025 Update & Verified Momentum Stock Watchlist - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) Price Target at $3.75 - Defense World

Oct 06, 2025
pulisher
Oct 05, 2025

Century Therapeutics Inc. recovery potential after sell offMarket Activity Recap & Risk Controlled Stock Pick Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How to build a dashboard for Century Therapeutics Inc. stockJobs Report & Community Consensus Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is Century Therapeutics Inc. stock ready for a breakoutMarket Risk Analysis & Fast Moving Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why Century Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com

Oct 03, 2025

Century Therapeutics Inc Stock (IPSC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Cap:     |  Volume (24h):